Urology · MU Plovdiv

8. Renal parenchymal tumours. Urothelial carcinoma of the renal pelvis, ureter and bladder. Urinary diversion after cystectomy.

Inside: 7 sections · 2 labelled pictures · 5 tables · 15 flashcards · 13 min

Essay 8 of 10 in the MU Plovdiv syllabus for Urology (Medicine, Year 4). The free AceMed note covers it in 7 sections, about 1,453 words (13 min of reading), with 15 flashcards.

In this note

  1. In brief
  2. Renal cell carcinoma (RCC)
  3. Upper tract urothelial carcinoma (UTUC)
  4. Bladder cancer
  5. Urinary diversion after cystectomy
  6. Exam lens: USMLE / PLAB
  7. References

In brief

  • Three cancers of the upper and lower urinary tract: renal cell carcinoma (from the tubular epithelium of the kidney), upper tract urothelial carcinoma (renal pelvis and ureter) and bladder cancer; a cystectomy then needs a urinary diversion.
  • Key to diagnosis: visible haematuria in an adult is cancer until proven otherwise; a renal mass is staged with contrast CT, a bladder tumour with cystoscopy and TURBT (transurethral resection of bladder tumour) that includes detrusor muscle.
  • Key to treatment: partial nephrectomy for T1 renal tumours; nephroureterectomy for high-risk upper tract tumours; TURBT plus intravesical therapy for non-muscle-invasive bladder cancer; neoadjuvant cisplatin then radical cystectomy for muscle-invasive disease.

Renal cell carcinoma (RCC)

Definition and epidemiology

RCC is a malignant tumour of the renal parenchyma arising from tubular epithelium; it makes up about 2% of adult cancers.

  • Men are affected about 1.5 times as often as women; peak age is 60–70 years.

Risk factors

  • Acquired: smoking, obesity, hypertension, long-term dialysis (acquired cystic kidney disease).
  • Hereditary (about 2–4%): von Hippel–Lindau disease (VHL gene, chromosome 3p; clear cell RCC), hereditary papillary RCC (MET), Birt–Hogg–Dubé syndrome, tuberous sclerosis, fumarate hydratase (FH) deficiency. Suspect a syndrome with young age, bilateral or multifocal tumours.

Classification (WHO 2022, 5th edition)

Grading is by the WHO/ISUP system, grades 1–4 (the Fuhrman grade is obsolete). Sarcomatoid change in any subtype means aggressive disease.

Clinical features

  • More than half are now found incidentally on imaging.
  • The classic triad of flank pain, haematuria and a palpable mass is present in under 10% and means advanced disease.
  • A left varicocele that does not empty when lying (tumour thrombus blocking the left renal vein) and leg oedema (caval involvement).
  • Paraneoplastic syndromes (about 30%): hypertension (renin), polycythaemia (erythropoietin), hypercalcaemia (PTH-related peptide), Stauffer syndrome (non-metastatic liver dysfunction), fever, anaemia, weight loss, raised ESR.
  • Metastases: lung (commonest), bone (lytic), liver, brain, adrenal.

Diagnosis

  • Ultrasound often finds the mass; contrast-enhanced CT characterises it: solid tissue that enhances by about 15–20 Hounsfield units or more is suspicious. MRI when contrast is contraindicated and to define venous thrombus.
  • Staging adds chest CT. Blood tests: creatinine/eGFR, calcium, haemoglobin, LDH, liver enzymes.
  • Biopsy is not routine before nephrectomy; it is used before ablation, active surveillance or systemic therapy.

Contrast CT: a large rounded mass in the left kidney enhances less than normal parenchyma (left to right: corticomedullary phase axial, coronal, parenchymal phase).

Continue reading free

The whole note, all 7 sections, is free with an AceMed account, with its 15 flashcards. Standard adds flashcard recall, highlights and Ask AI.